J3246 Tirofiban hcl
J-Codes
Also known as: tirofiban, Aggrastat, glycoprotein IIb/IIIa inhibitor
Tirofiban hydrochloride injection is a platelet glycoprotein IIb/IIIa inhibitor used to prevent thrombotic cardiovascular events during coronary intervention.
Clinical Context
Indicated during percutaneous coronary intervention to prevent acute ischemic complications. Inhibits platelet aggregation. Administered intravenously with loading bolus followed by infusion during and after coronary procedure.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.